CAS 928326-83-4,Vargatef Base or BIBF-1120,BIBF 1120,BIBF1120

Basic Info

Model No.: 928326-83-4

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Ocean,Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Product Description

Nintedanib referred to as Vargatef Base or BIBF-1120,BIBF 1120,BIBF1120, CAS number is 928326-83-4. It is an anti-tumor drug. In the treatment of idiopathic pulmonary fibrosis (IPF) worthy of our expectations. IPF is a fatal lung disease that is severely endangered by humans, with a median survival after diagnosis of only 2 to 3 years. Prior to Nidanib, there was no FDA approval for the treatment of IPF. Nintedanib has previously been awarded the groundbreaking treatment by the FDA, and the approval also makes Nintedanib become the first and only tyrosine kinase inhibitor (TKI) approved for the treatment of IPF.

Thera. Category: A Potent Kinase Inhibitor

Cas No.: 928326-83-4

Synonym:  Vargatef Base or BIBF-1120;BIBF1120,BIBF-1120,Vargatef;VargatefTM BIBF;Nintedanib Esylate(BIBF-1120);Nintedanib, >=98%;BIBF-1120;BIBF-1120(Vargatef);VARGATEF ( BIBF1120 );

Molecular Formula: C31H33N5O4

Molecular Weight: 539.633

Purity: ≥98.%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

BIBF1120 (Vargatef)  is an indolinone derivative potently blocking VEGF-, PDGF-, and FGF-receptor kinases; an indolinone as triple angiokinase inhibitors.

1) Methyl 2-oxoindole-6-carboxylate CAS 14192-26-8

2) Methyl 1-acetyl-2-oxoindoline-6-carboxylate  CAS 676326-36-6